4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-001489
CHIEF COMMERCIAL OFFICER sold 7,180 shares at $37.04 ($265,946)
- CHIEF COMMERCIAL OFFICER acquired 7,180 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-13 | Option exercise 10b5-1 | +7,180 | $33.44 | $240,099 | 7,180 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-13 | Sale 10b5-1 | −7,180 | $37.04 | $265,946 | 0 | D |
| Derivatives | |||||||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-13 | Option exercise · Stock Option 10b5-1 | −7,180 | 46,720 | D | ||
| Open-market sales · 7,180 sh · avg $37.04 · $265,946 | |||||||
Loading xslF345X05/form4-01152025_040125.xml…